Structure-Guided Design and Optimization of Small Molecules Targeting the Protein–Protein Interaction between the von Hippel–Lindau (VHL) E3 Ubiquitin Ligase and the Hypoxia Inducible Factor (HIF) Alpha Subunit with in Vitro Nanomolar Affinities

Citations Over TimeTop 10% of 2014 papers

Abstract

E3 ubiquitin ligases are attractive targets in the ubiquitin-proteasome system, however, the development of small-molecule ligands has been rewarded with limited success. The von Hippel-Lindau protein (pVHL) is the substrate recognition subunit of the VHL E3 ligase that targets HIF-1α for degradation. We recently reported inhibitors of the pVHL:HIF-1α interaction, however they exhibited moderate potency. Herein, we report the design and optimization, guided by X-ray crystal structures, of a ligand series with nanomolar binding affinities.

Related Papers

• → Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity(2018)286 cited
• → A Comprehensive Atlas of E3 Ubiquitin Ligase Mutations in Neurological Disorders(2018)171 cited
• → ELIOT: A platform to navigate the E3 pocketome and aid the design of new PROTACs(2022)20 cited
• → Identification of the phosphorylation sites on the E3 ubiquitin ligase Pellino that are critical for activation by IRAK1 and IRAK4(2009)75 cited
• → E1B 55k-independent dissociation of the DNA ligase IV/XRCC4 complex by E4 34k during adenovirus infection(2008)20 cited